Freeze-Fight-Flush: new combo therapy aims to save bladders in High-Risk cancer
NCT ID NCT07204132
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This study tests a new approach to treat high-risk bladder cancer without removing the bladder. It combines freezing the tumor during surgery, immunotherapy, and low-dose chemotherapy. The goal is to see if this combo can help patients live longer and keep their bladder, compared to standard bladder removal surgery. The study plans to enroll 180 adults with high-risk non-muscle-invasive bladder cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ChangHai Hospital
RECRUITINGShanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.